What is the official website of Enclara Pharmacia ?

The official website of Enclara Pharmacia is https://enclarapharmacia.com/.

What is Enclara Pharmacia's cybersecurity risk score?

Enclara Pharmacia has an AI-generated cybersecurity risk score of 755 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Enclara Pharmacia experienced?

According to Rankiteo, Enclara Pharmacia currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Enclara Pharmacia been affected by any supply chain cyber incidents ?

According to Rankiteo, Enclara Pharmacia has been affected by a supply chain cyber incident involving Future Cardia, with the incident ID HUMORAHEACEN1774290394.

Does Enclara Pharmacia have SOC 2 Type 1 certification ?

According to Rankiteo, Enclara Pharmacia is not certified under SOC 2 Type 1.

Does Enclara Pharmacia have SOC 2 Type 2 certification ?

According to Rankiteo, Enclara Pharmacia does not hold a SOC 2 Type 2 certification.

Does Enclara Pharmacia comply with GDPR ?

According to Rankiteo, Enclara Pharmacia is not listed as GDPR compliant.

Does Enclara Pharmacia have PCI DSS certification ?

According to Rankiteo, Enclara Pharmacia does not currently maintain PCI DSS compliance.

Does Enclara Pharmacia comply with HIPAA ?

According to Rankiteo, Enclara Pharmacia is not compliant with HIPAA regulations.

Does Enclara Pharmacia have ISO 27001 certification ?

According to Rankiteo,Enclara Pharmacia is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Enclara Pharmacia operate in ?

Enclara Pharmacia operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Enclara Pharmacia have ?

Enclara Pharmacia employs approximately 525 people worldwide.

Does Enclara Pharmacia own any subsidiaries ?

Enclara Pharmacia presently has no subsidiaries across any sectors.

How many LinkedIn followers does Enclara Pharmacia have ?

Enclara Pharmacia's official LinkedIn profile has approximately 7,330 followers.

What is the NAICS classification code for Enclara Pharmacia ?

Enclara Pharmacia is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Enclara Pharmacia have a Crunchbase profile ?

Yes, Enclara Pharmacia has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/enclara-health.

Does Enclara Pharmacia have a LinkedIn profile ?

Yes, Enclara Pharmacia maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/enclara-pharmacia.

How many cybersecurity incidents has Enclara Pharmacia experienced ?

As of August 27, 2026, Rankiteo reports that Enclara Pharmacia has experienced 9 cybersecurity incidents.

How many peer or competitor companies does Enclara Pharmacia have ?

Enclara Pharmacia has an estimated 5,737 peer or competitor companies worldwide.

What types of cybersecurity incidents has Enclara Pharmacia faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Ransomware, Breach and Cyber Attack.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Enclara Pharmacia

Boost Score +25 with badge (5 left)

755

/1000

Fair

780

/1000

Fair

Enclara Pharmacia Vendor Cyber Rating & Cyber Score

enclarapharmacia.com

cb in

Add Your Compliance Badge

As the nation’s leading pharmacy solutions provider for the hospice and palliative care community, Enclara Pharmacia empowers people to transform hospice care through collaboration, creativity, and compassion. Through a comprehensive network of retail and institutional pharmacies, a national patient-direct dispensing program and dedicated inpatient services, Enclara ensures timely and reliable medication access in any care setting. Combining clinical expertise, proprietary technology and a patient-focused, nurse-centric approach, Enclara enables hospices of all sizes and models to improve quality of life for individuals experiencing progressive illness. You Deliver the Care. We Make It Easier. For more information, visit

Enclara Pharmacia A.I CyberSecurity Scoring

Scoring History

Enclara Pharmacia

Enclara Pharmacia CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Humana

Ransomware

100

8/2025

Future Cardia

HUMORAHEACEN177...

Enclara Pharmacia

Breach

8/2023

HUM143072625

Enclara Pharmacia

Cyber Attack

5/2023

HUM030090625

Enclara Pharmacia

Breach

09/2022

HUM232025922

Enclara Pharmacia

Breach

5/2022

HUM033091825

Enclara Pharmacia

Ransomware

100

4/2021

HUM511080425

Enclara Pharmacia

Breach

10/2020

HUM806072625

Enclara Pharmacia

Breach

5/2018

HUM1046072525

Enclara Pharmacia

Breach

02/2018

CAR10557622

Loading…

A.I.

Enclara Pharmacia Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Enclara Pharmacia

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Enclara Pharmacia in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Enclara Pharmacia in 2026.

Incident Types Enclara Pharmacia vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Enclara Pharmacia in 2026.

Incident History - Enclara Pharmacia (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Enclara Pharmacia Subsidiaries

Enclara Pharmacia

Pharmaceutical Manufacturing

Website: https://enclarapharmacia.com/

Company Size: 525

HumanaInsurance

Humana FoundationPhilanthropy

OneHomeHospitals and Health Care

Conviva Senior Primary CareHospitals and Health Care

Harris Rothenberg InternationalHealth, Wellness & Fitness

Arcadian Health PlanHospitals and Health Care

CarePlus Health PlansInsurance

Loading…

Enclara Pharmacia Similar Companies

Eli Lilly and Company

lilly.com

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.

Grifols

cb linktr.ee

Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases. With a workforce of over 23,000 employees in more than 30 countries and regions, we are committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. People are at the heart of what we do, and we strive to create an inclusive, diverse, fair and equal society. Maintaining and promoting a workforce that reflects this reality leads to enhanced professional relationships and helps us to give our best to patients, donors and customers. In 2024, Grifols was named one of TIME’s ‘World’s Best Companies’ for the second year in a row, reaffirming our commitment to excellence. We were also recognized by Forbes as one of the "Best Employers for Women 2023," reflecting our dedication to fostering an inclusive and supportive workplace for all. To maintain a positive community and overall respectful communication, please keep our community guidelines in mind.

Alembic Pharmaceuticals Limited

alembic-india.com

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara.

Bristol Myers Squibb

cb bms.com

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html

Hikma Pharmaceuticals

cb hikma.com

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe. We have 29 manufacturing plants, 3 R&D hubs and c9,500 employees worldwide. *As of December 2025 Subscribe to our channel on YouTube https://youtube.com/@hikmapharmaceuticals5668 For all product information and enquiries, please contact us at [email protected]

MSD

msd.com

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.

Lupin

lupin.com

Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.

MENARINI Group

menarini.com

The Menarini Group is a leading international pharmaceutical and diagnostics company, present in 140 countries worldwide, with a turnover of 4,37 Billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, infectious diseases, diabetes, and anti-inflammatory/analgesics. The Group’s pharmaceutical production is carried out in its 18 manufacturing plants, which produce over 609 million packets of product a year and distribute them to five continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients all over the world. For further information, please visit www.menarini.com For reading our Netiquette, please visit https://www.menarini.com/en-us/data-privacy/netiquette-of-menarini-group For reading our Privacy Notice for social networks users, please visit https://www.menarini.com/en-us/data-privacy/privacy-notice-for-social-network-users-of-menarini-group

Catalent

catalent.com

Championing the missions that matter™. Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) and trusted partner to pharma, biotech, and consumer health companies worldwide. We put patients first in everything we do, helping people live better and healthier lives through every product we help develop, manufacture and deliver. With over 1,000 active development programs at any given time, we launch over 100 new products and line extensions annually. Catalent has supported half of all FDA approvals over the past decade, and our teams working at over 40 global sites help us produce over 60 billion doses every year. Our strength lies in our people: teams across our more than 40 sites and thousands of passionate scientists and technicians who bring expertise in development sciences, delivery technologies, and multi-modality manufacturing. What unites us is our commitment to championing our partners’ missions as our own, anticipating customer needs, solving complex challenges and ultimately making a difference in the lives of patients across the globe. At Catalent, you will be able to directly have an impact, solving problems and ensuring excellence for our customers. Our focus on delivering meaningful outcomes alongside our customers means your work directly impacts millions of people around the world. Join us in championing the missions that matter. Catalent is headquartered in Tampa, Florida, with over 40 global sites. Visit www.catalent.com to learn more.

Loading…

NEWS

Enclara Pharmacia CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

July 30, 2025 07:00 AM

Enclara Pharmacia and FireNote develop new feature to enhance hospice operations

The enhancement enables new FireNote clients to directly download patient medication profiles from Enclara into FireNote's system.

Read Article

April 09, 2025 07:00 AM

Enclara Pharmacia Launches Next-Day Shipping Infusion Services to Support Hospice Providers

PHILADELPHIA, April 09, 2025--Enclara Pharmacia, the nation's leading hospice pharmacy solutions provider, has announced the launch of...

Read Article

December 16, 2019 08:00 AM

Humana to Acquire Enclara Healthcare

LOUISVILLE, KY and PHILADELPHIA, PA (December 16, 2019) – Humana Inc. (NYSE: HUM) today announced it has signed a definitive agreement to acquire privately...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-81203

SUMMARY

A vulnerability has been found in SourceCodester Simple Online Food Ordering System 1.0. This affects an unknown function of the file /admin/ajax.php?action=login2. The manipulation of the argument email leads to sql injection. It is possible to initiate the attack remotely. The exploit has been disclosed to the public and may be used.

Published

Date2026-08-26

Updated

Date2026-08-26

RISK INFORMATION (Score: 7.3)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:P/A:P

cvss3

Base Score: 7.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

3.9

REFERENCES

CVE-2026-80158

SUMMARY

A flaw was found in the ipa_getkeytab module of the community.general Ansible collection. The module's bind_pw parameter, used to supply the LDAP simple-bind password when retrieving a Kerberos keytab, is not declared with no_log, unlike the sibling password parameter in the same module. As a consequence, the supplied IPA/LDAP bind password is recorded in cleartext in the managed host's system journal/syslog (the module's "Invoked with" record), is included in the module's return values and verbose (-v) output, and is displayed in Automation Controller / AWX job output. The password is additionally passed on the command line to the ipa-getkeytab helper (as --bindpw <value>), exposing it in the process list to local users while the command runs. An attacker able to read these logs, job output, or the process table can obtain the directory bind credential, potentially compromising the accounts and objects that credential can access.

Published

Date2026-08-26

Updated

Date2026-08-26

RISK INFORMATION (Score: 5.5)

cvss3

Base Score: 5.5

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

Impact Score

3.6

Exploitability

1.8

REFERENCES

CVE-2026-75340

SUMMARY

The device metadata import interface /device/instance/{productId}/property-metadata/import of jetlinks community 2.11 is vulnerable to Server-side request forgery (SSRF).

Published

Date2026-08-26

Updated

Date2026-08-26

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

https://github.com/fangtang7/CVE/blob/main/jetlinks-community/ssrf.md

CVE-2026-75338

SUMMARY

disconf (Distributed Configuration Management Platform) 2.6.36 is vulnerable to Incorrect Access Control. The config-fetching APIs /api/config/item, /api/config/file, /api/config/list and /api/config/simple/list are exposed without authentication. The LoginInterceptor explicitly whitelists these four paths, so any anonymous attacker can read every configuration item and configuration file managed by the config center.

Published

Date2026-08-26

Updated

Date2026-08-26

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

https://github.com/fangtang7/CVE/blob/main/disconf/Unauthenticated.md

CVE-2026-75336

SUMMARY

Funiture 1.0.0 is vulnerable to SQL Injection in the backend tool interfaces /sys/tool/select.json and /sys/tool/update.json.

Published

Date2026-08-26

Updated

Date2026-08-26

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

https://github.com/fangtang7/CVE/blob/main/funiture/SQL%20Injection.md

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…